A temporary pause of the BTAA Helpline Support Service

A temporary pause of the BTAA Helpline Support Service

The BTAA Helpline service to callers requesting support for brain tumours and related neurological issues will be temporarily paused for a period of review and reassessment. While we are unable to take your call during this period, we wish to redirect your concerns or...
Vale Professor Richard Scolyer AO

Vale Professor Richard Scolyer AO

BTAA shares this statement on behalf of BTAA and the Australian Brain Tumour Collaborative (ABTC). Today, on World Brain Tumour Awareness Day, we honour the life and legacy of Professor Richard Scolyer AO — a giant of Australian science, a courageous patient, and an...
BTAA Board Announcement – May 2026

BTAA Board Announcement – May 2026

Brain Tumour Alliance Australia is pleased to announce the appointment of its new Board, bringing together leaders in governance, advocacy, research engagement and lived experience to strengthen national advocacy for all Australians affected by brain tumours. At the...
Head to the Hill – October 2025

Head to the Hill – October 2025

Head to the Hill 2025 saw patients, carers, clinicians and researchers come together to share their stories and advocate directly to federal MPs about the urgent needs of the brain tumour community. From personal stories, calls for funding and support from MPs, the...
New Research Into Brain Cancer’s Impact on Society

New Research Into Brain Cancer’s Impact on Society

BTAA announces new research into the staggering economic burden of Brain Cancer on society, detailing the burden of disease and outlining key initiatives in research and support that can make a difference. The societal financial cost is estimated to be $3.2 billion by...
Monash University. We want to hear your story!

Monash University. We want to hear your story!

Are you a parent, caregiver, or young person with experience of paediatric low-grade glioma (pLGG) in Australia? As part of a Monash University Honours research project, in collaboration with Ipsen Pharmaceuticals*, we’re developing a Patient Journey Map (PJM) to...